Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine

Ashish K. Gadicherla; David F. Stowe; William E. Antholine; Meiying Yang; Amadou K.S. Camara

doi:10.1016/j.bbabio.2011.11.021

ScienceGate Book Chapters

JOURNAL ARTICLE

Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine

Ashish K. Gadicherla David F. Stowe William E. Antholine Meiying Yang Amadou K.S. Camara

Year: 2011 Journal: Biochimica et Biophysica Acta (BBA) - Bioenergetics Vol: 1817 (3)Pages: 419-429 Publisher: Elsevier BV

DOI: 10.1016/j.bbabio.2011.11.021

Get Full-Text PDF Get Analytical Report

Keywords:

Ranolazine Pharmacology Ischemia Chemistry Cardiolipin Mitochondrion Coenzyme Q – cytochrome c reductase Biochemistry Medicine Internal medicine Cytochrome c

Metrics

Cited By

3.58

FWCI (Field Weighted Citation Impact)

Refs

0.96

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Electron Spin Resonance Studies

Life Sciences → Biochemistry, Genetics and Molecular Biology → Biophysics

Cardiac electrophysiology and arrhythmias

Health Sciences → Medicine → Cardiology and Cardiovascular Medicine

Electrochemical Analysis and Applications

Physical Sciences → Chemistry → Electrochemistry

Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine

Metrics

Citation History

Topics

Related Documents

Ranolazine Reduces Mitochondrial Tyrosine Nitration During Cardiac Ischemia and Reperfusion Injury

The Anti-Anginal Drug Trimetazidine Reduces Neutrophil-Mediated Cardiac Reperfusion Injury

Mitochondrial Formyl Peptide Attenuates Cardiac Damage Induced By Ischemia/Reperfusion Injury

Ischemia-reperfusion injury–induced pulmonary mitochondrial damage

INTRA-MITOCHONDRIAL INJURY DURING ISCHEMIA-REPERFUSION